Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Kidney Neoplasms × Axitinib × Clear all

Phase

Status

Completed 8 Recruiting 3 Unknown 1 Terminated 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 2 Kidney Neoplasms 1 Advanced Renal Cell Carcinoma (aRCC) 1

Interventions

Pluvicto 2 zimberelimab 1 vorolanib 1 palbociclib 1 cabozantinib 1 Urination 1 Tumor Burden 1 Sunitinib 1 Radiosurgery 1 Nivolumab 1 Nephrectomy 1 Ipilimumab 1 Histocompatibility Testing 1 Blood Specimen Collection 1 Bariatric Surgery 1 Axitinib 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07123090 2026-02-27

SPARCC

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡